Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 7 for:    progeria
Previous Study | Return to List | Next Study

Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by Children's Hospital Boston
Sponsor:
Collaborators:
Progeria Research Foundation
Schering-Plough
Information provided by (Responsible Party):
Mark Kieran, Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00916747
First received: June 5, 2009
Last updated: August 7, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)
No publications provided by Children's Hospital Boston

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):